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Abstract
Background: A feature of the Asian Indian phenotype is low birth weight with increased adult type 2 diabetes risk. Most
populations show consistent associations between low birth weight and adult type 2 diabetes. Recently, two birth weight-
lowering loci on chromosome 3 (near CCNL1 and ADCY5) were identified in a genome-wide association study, the latter of
which is also a type 2 diabetes locus. We therefore tested the impact of these genetic variants on birth weight and adult
glucose/insulin homeostasis in a large Indian birth cohort.
Methodology/Principal Findings: Adults (n = 2,151) enrolled in a birth cohort (established 1969-73) were genotyped for
rs900400 (near CCNL1) and rs9883204 (ADCY5). Associations were tested for birth weight, anthropometry from infancy to
adulthood, and type 2 diabetes related glycemic traits. The average birth weight in this population was 2.7960.47 kg and
was not associated with genetic variation in CCNL1 (p= 0.87) or ADCY5 (p= 0.54). Allele frequencies for the ‘birth weight-
lowering’ variants were similar compared with Western populations. There were no significant associations with growth or
adult weight. However, the ‘birth weight-lowering’ variant of ADCY5 was associated with modest increase in fasting glucose
(b 0.041, p= 0.027), 2-hours glucose (b 0.127, p= 0.019), and reduced insulinogenic index (b -0.106, p= 0.050) and 2-hour
insulin (b -0.058, p = 0.010).
Conclusions: The low birth weight in Asian Indians is not even partly explained by genetic variants near CCNL1 and ADCY5
which implies that non-genetic factors may predominate. However, the ‘birth-weight-lowering’ variant of ADCY5 was
associated with elevated glucose and decreased insulin response in early adulthood which argues for a common genetic
cause of low birth weight and risk of type 2 diabetes.
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Introduction
A recent genome-wide association (GWA) study identified two
independent loci on chromosome 3 (rs900400 near CCNL1 and
rs9883204 of ADCY5) for low birth weight [1]. When replicated in
Europeans robust associations (p=3610226 and 361029, respec-
tively) with birth weight were observed leading to a 113 g
difference between homozygous carriers vs. non-carriers for the
two respective variants [1].
Indian new born babies generally weigh the least in the world
with a mean birth weight at term being 2.6 to 2.9 kg compared to
3.5 to 3.7 kg among Europeans [2,3]. The discovery of genetic
variants having a strong effect on birth weight therefore provides
the opportunity to test if some of the low Indian birth weight has a
genetic component.
A systematic review of the relationship between birth weight
and subsequent risk of development of type 2 diabetes in
adulthood has shown an inverse relationship that is consistent
between populations [4]. Although the exact mechanism for this
relationship remains unclear, the fetal-insulin hypothesis describes
a distinct role for a genetic and environmental component for the
association [5]. An alternative, but neither opposing, nor exclusive,
explanation is through fetal programming due to the in utero
environment [6]. However, this latter explanation remains
mechanistically elusive.
Genetic variants that influence fetal insulin secretion or insulin
sensitivity appear to be important determinants of fetal growth,
and subsequent development of type 2 diabetes [7]. Associations
between mutations in the INS, INSR, IPF1, KCNJ11, ABCC8 and
HNF1B genes reducing fetal insulin secretion and markedly
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reducing birth weight in monogenic diabetes provide support for a
genetic role in the modulation of birth weight, although this
cannot be extrapolated to the general population due to the rarity
of these mutations [5,8–10]. There is some evidence from the
study of common genetic variants related to type 2 diabetes
(TCF7L, GCK, I/III polymorphisms of INS-VNTR and IGF-1) and
its effects on birth weight, lending support to the notion that more
moderate impairment of insulin secretion provides a link between
inheritance of type 2 diabetes susceptibility and reduced weight at
birth [11–14]. More recently genetic variants near ADCY5 have
been linked to glycemic traits in healthy individuals [15], and with
birth weight in the Danish Inter99 population [16].
Therefore, we aimed to replicate two ‘birth weight-lowering’
alleles (rs900400 near CCNL1 and rs9883204 of ADCY5) in a
longitudinal birth cohort form South India and also test whether
the low Indian birth weight is driven, or partly explained, by
similar genetic factors as in Europeans. In this replication there
are two inherent questions. First, whether the low birth in Indians
is due to higher frequencies of ‘birth weight-lowering’ alleles
compared to the Western population and secondly, whether the
lower average birth weight is modulated by variants in ADCY5 and
near CCNL1 in a way similar to the western population. Due to the
known associations between birth weight and adult type 2 diabetes
and the fact that one of the ‘birth weight-lowering’ alleles (ADCY5)
also appears to be a genetic determinant of glycemic traits, we also
aimed to investigate possible associations of CCNL1 and ADCY5
genotypes with diabetes related intermediate-traits in addition to
investigating the influence of these SNPs on anthropometric traits
during longitudinal follow-up from birth to adulthood.
Materials and Methods
Ethics Statement
All study participants gave written informed consent and the
protocol was in accordance with the Helsinki Declaration, and
approved by the Institutional Ethics committee and Review board
of Christian Medical College & Hospital, Vellore, India.
Cohort description
The current study included 2,151 adults aged 26–32 (mean
28.361.10) years, drawn from an original birth cohort of 10,691
singleton births during 1969–1973 in one of 24 wards of Vellore
town and adjoining rural villages, Tamil Nadu, India. Details of the
original cohort are described elsewhere [17]. Complete birth
measurements were available for 4,092 (2,790 from rural and 1,302
from Urban dwelling) individuals and 2,218 out of 2,572 members
retraced during 1999–2002 agreed to take part in a study of glucose
tolerance and cardiovascular risk factors, reported earlier [18]. The
original cohort was followed up at several time points of growth and
development from birth, through infancy (1–3 months), childhood
(6–8 years) and adolescence (10–15 years) and adulthood. A total of
2,151 (1,175 of rural birth and 976 of urban birth) participants (out
of 2,218 retraced) had adequate DNA samples and were included in
the current study. Based on WHO criteria, there were 83 (3.9%)
subjects with impaired fasting glucose (IFG) (.6.1 but below
7.0 mmol/l), 319 (14.8%) with impaired glucose tolerance (IGT) (2-
hours blood glucose .8 mmol/l) and 55 (2.6%) with manifest type
2 diabetes (T2DM), demonstrated by an oral glucose tolerance test.
Anthropometric measurements and biochemical analysis
Anthropometric measurements included height, weight, waist
and hip circumference measured by standard methods during
adulthood. Body fat percentage was calculated from four skinfold
measurements [19,20]. Plasma glucose and insulin were recorded
at 0, 30, 60 and 120 minutes, following a 75 g oral glucose
tolerance test (after 12 hours of overnight fasting). Plasma glucose
concentrations were measured by glucose oxidase/peroxidase
methods, and serum lipids using commercial enzymatic kits
(Roche Diagnostics, Germany) on a Hitachi 911 autoanalyser
(USA). Plasma insulin was measured by an immunoradiometric
assay using Coat-a-Count kits (Diagnostic Products Corporation,
USA). The quality of these measurements was assessed using
Roche Precinorm and Precipath controls for glucose and lipids
and BioRad Lyphocheck Immunoassay controls for insulin. Intra-
and inter-assay coefficients of variation for insulin estimations were
8.0–14.5 and 8.2–13.0% respectively. HOMA-IR and HOMA-B
were calculated using an algorithm from http://www.dtu.ox.ac.
uk/homacalculator/index.php. All biochemical measurements
were done centrally at the Department of Clinical Biochemistry,
Christian Medical College & Hospital, Vellore, on samples that
were collected during adulthood (in 2002).
Genotyping
DNA was extracted from peripheral blood using Qiagen kits.
The samples were genotyped using 10–20 ng genomic DNA in
384-well format on an ABI 7900 machine at final volume of 4 ml.
The genotyping was performed using TaqManH SNP Geno-
typing Assays C1860681_10 and C3035719_20 for rs900400 (near
CCNL1) and rs9883204 (ADCY5), respectively. The TaqManH
genotyping master mix was used following the manufacturer’s
conditions. Genotyping quality control was tested in 8.6% of the
samples (genotyped in duplicate) with 0% difference in genotype.
Genotyping failed in 65 (3.0%) for rs900400 and 61 (2.8%) for
rs9883204, most probably due to low quality DNA for the
platform used.
Statistical methods
We tested the association between quantitative phenotypes and
SNPs using ANOVA for normally distributed variables and
Kruskal–Wallis test for skewed variables, adjusted for gender.
Linear regression analysis was performed for each of the glycemic
trait as the dependent variable against genotypes (additive model)
as independent variables, with age, gender, consanguinity and
BMI as covariates. Z-scores for selected anthropometric variables
were age-adjusted and converted into within-cohort age- and
sex-specific Z-scores [(subject mean- cohort mean)/cohort SD]
considering variations in ages measured at different time points.
The cohort mean and SD were derived from all 4,092 individuals
with complete birth and parental measurements. Infant data were
included if there was at least one measurement between 1 and 3
months, and the latest available time point used. Childhood data
were included if there was at least one measurement between 6
and 8 years, and the average Z-score was used if there were more
than one measurement. Adolescent data were included if there was
at least one measurement between 10 and 14 years, the Z-score for
the age closest to 12 years being selected. The main analysis used
all available data at each time point. The absolute effect of genetic
variants on Z-scores of anthropometry was assessed using
ANOVA after adjustment for gestational age, gender and
consanguinity. Effect size of the additive model was computed
using regression models adjusted for gestational age, gender and
consanguinity. All data were analyzed using STATA (Version
11.0). Subjects with T2DM (n= 55) were excluded from all
analysis. All diabetes related traits except 2 hours postprandial
glucose and AUC glucose were log transformed to obtain normal
distribution before analysis.
A power calculation based on variance explained by both the
genetic variants (0.3% for CCNL1 and 0.1% for ADCY5) as
ADCY5 and Impaired Insulin-Glucose Signaling
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previously described, showed a power of 74% and 32% to detect a
variance (r2) explained, for CCNL1 and ADCY5 respectively using
adjusted models, calculated at an alpha (0.05), and a sample size of
2,151. The coefficient of variation (CV) of birth weight was 18.8%
for CCNL1 and 16.7% for ADCY5 and this was comparable to the
effects demonstrated by these variants on birth weight as described
by Freathy RM et al [1].
Results
There were no significant associations between either rs900400
(near CCNL1) or rs9883204 (ADCY5) with birth weight in the
Indian population (Table 1). The allele frequencies of the ‘birth
weight-lowering’ alleles were 0.21 for C allele (rs900400) and 0.81
for C allele (rs9883204). The rs9883204 showed some loss of
expected heterozygosity and did not follow Hardy–Weinberg
equilibrium (X2 4.45, p=0.035) in the cohort. This is a well-
known phenomenon in cohorts with a high degree of consan-
guineous parentage, which was the case in 47% of the rural part of
the cohort and 29% in the urban group.
Comparing birth weights in extreme homozygotes (CC) for
both of the ‘birth weight-lowering’ variants, no statistically sig-
nificant difference between carriers (2,7726535 g, n= 62) and
non-carriers (2,7826552 g, n = 53, p=0.10) was observed.
We then compared the birth weights for participants with
normoglycemia, IFG, IGT and manifest type 2 diabetes (T2DM)
in the entire cohort. The mean birth weight among people with
normoglycemia was 2,7956460 g (n = 1,694), with IFG (n= 83)
2,7546505 g, with IGT (n= 319) was 2,7636496 g and
2,7156536 g in the diabetes group (n = 55). The difference
appeared largest between the normoglycemic group and the
groups with manifest type 2 diabetes, but this was not statistically
significant (p=0.24).
There was no significant relationship between either of the
genotypes and Z-scores of anthropometry measured across various
time periods at birth, infancy, childhood, adolescence or
adulthood (Table S1). Neither of the SNPs in additive model
showed significant association with any of the anthropometric
measures of obesity in adulthood. (Table 1), and this signal was not
picked up by either the BMI or waist circumference measure-
ments. The additive model of ADCY5 variant was associated with
raised 2-hour glucose postprandially (p=0.010) (Table 2).
Regression analysis showed that the ‘birth weight-lowering’
variant of ADCY5, was significantly and positively associated with
increase in 2-hour glucose, fasting glucose, reduced insulinogenic
index and reduced 2-hour insulin (Table 2). Since the rise in
2-hour glucose is dependent on the rate of peripheral glucose
disposal, we presumed that fasting glucose may confound this
association. However, we found that the association of ADCY5
variant with 2-hour glucose remained significant even after
adjusting for fasting glucose (Logged b 0.102, p=0.053). The
‘birth weight-lowering’ variants were not associated with calculat-
ed index of insulin resistance (HOMA-IR). No impairment of b-
cell function was observed for variants at the CCNL1 locus
(Table 3).
To further analyze the impact on postprandial glycemia in
the homozygous carriers of the ADCY5 variant, we calculated
the frequency of having plasma glucose above an arbitrary cut-
off of 9 and 11 mmol/L, respectively. The lower level was
chosen to enhance the capacity to detect even lower glycemic
disturbances in these apparently healthy and young adults. At
the 9 mmol/L cut off, the odds ratio (OR) and 95% confidence
Table 1. Demographic characteristics of the birth cohort.
CCNL1 (rs900400) ADCY5 (rs9883204)
TT (n=1258) TC (n=679) CC (n=96) P value TT (n=87) CT (n=610) CC (n=1339) P value
Age (years) 28.4 (1.12) 28.4 (1.08) 28.2 (1.06) 0.59 28.3 (1.13) 28.4 (1.12) 28.3 (1.09) 0.49
Gender (% female) 582 (46.26) 360 (53.02) 39 (40.63) 0.86 43 (49.43) 301 (49.34) 644 (48.10) 0.006
Birth Weight (kg) 2.79 (0.47) 2.80 (0.45) 2.80 (0.53) 0.87 2.77 (0.55) 2.80 (0.46) 2.78 (0.46) 0.54
Adult Weight (kg) 53.2 (11.58) 53.3 (11.60) 55.5 (12.18) 0.13 52.4 (11.97) 53.2 (11.44) 53.5 (11.65) 0.80
BMI (kg/m2) 20.6 (3.79) 20.8 (3.81) 21.0 (3.94) 0.42 20.3 (4.16) 20.7 (3.80) 20.7 (3.76) 0.64
Waist circumference (cm) 74 (10.5) 74 (10.6) 76 (10.4) 0.21 73 (9.62) 74 (10.63) 74 (10.48) 0.66
Hip circumference (cm) 88 (8.2) 88 (8.1) 88 (8.5) 0.39 87 (8.98) 88 (8.04) 88(8.15) 0.78
Systolic BP (mm Hg) 107 (12.2) 106 (11.9) 109 (13.6) 0.39 106 (11.9) 107 (11.9) 107 (12.3) 0.44
Diastolic BP (mm Hg) 72 (8.89) 73 (9.05) 73 (8.53) 0.44 71 (8.32) 72 (8.96) 73 (8.82) 0.11
*Body fat % 23.3 (9.63) 24.5 (9.54) 23.0 (9.76) 0.52 23.0 (10.10) 23.7 (9.83) 23.7 (9.51) 0.44
Skin fold thickness: Triceps (mm) 10.3 (6.6,16.5) 11 (7.1,17.5) 10.5 (6.1,15.1) 0.07 8.7 (5.9,17.4) 10.9 (7,17.2) 10.5 (6.8,16.5) 0.22
Skin fold thickness: Biceps (mm) 4.8 (3.3,7.6) 5.3 (3.4,8) 4.4 (3.4,7.3) 0.09 4.5 (3,8.1) 5 (3.5,8) 5 (3.4,7.7) 0.57
Skin fold thickness: Subscapular (mm) 16.7 (10.7,27.3) 17.1 (11.4,28.6) 15.3 (10.1,29.4) 0.26 16.8 (9.8,26.8) 16.9 (11,28.3) 16.9 810.9,28) 0.62
Skin fold thickness: Abdomen (mm) 18.5 (9.6,32.3) 19.9 (11.1,33.5) 22.7 (10, 33.5) 0.15 17.7 (8.4,29.3) 18.8 (10.1,32.6) 19.5 (10.1,33.4) 0.35
Total Cholesterol (mmol/l) 4.0 (0.89) 4.0 (0.83) 4.1 (0.89) 0.55 3.7 (0.76) 4.0 (0.87) 3.9 (0.87) 0.033
Triglycerides (mmol/l) 1.1 (0.70) 1.1 (0.60) 1.1 (0.78) 0.97 1.1 (0.68) 1.0 (0.63) 1.1 (0.69) 0.33
HDL-C (mmol/l) 1.0 (0.24) 1.0 (0.24) 1.1 (0.24) 0.35 1.0 (0.20) 1.0 (0.24) 1.0 (0.24) 0.33
LDL-C (mmol/l) 2.4 (0.74) 2.5 (0.72) 2. 5(0.75) 0.53 2.3 (0.64) 2.5 (0.76) 2.4 (0.72) 0.017
Data represented as Mean (SD) for all traits. Skin fold thickness is presented as median ( Interquartile range).
doi:10.1371/journal.pone.0021331.t001
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was 1.64 (1.08–2.48) p= 0.016, whereas there was no significant
effect at the 11 mmol/L cut off (OR 1.07, 95%CI 0.56–2.04,
p = 0.84).
Discussion
Genetic variants associated with a birth weight-lowering effect
in other populations, near CCNL1 or in ADCY5 locus are not
associated with birth weight in this Indian cohort, but the ‘birth
weight-lowering’ variant of ADCY5 was associated with raised
glucose and reduced early phase insulin secretion.
The Indian birth weight is generally about 0.8 kg less compared
to the West [21], and the mean birth weight in our cohort was
2.8 kg. Not only was there any modulation between genotypes at
this lower level, the gene frequencies of the ‘birth weight-lowering’
variants in ADCY5 and near CCNL were also the same (ADCY5) or
lower (CCNL) than in the original report in Europeans [1]. The
absence of an association between ‘birth weight-lowering’ genetic
variants and birth weight is therefore likely to be attributed to
strong environmental influences which dominate over the genetic
effects. This would be supported by the observations of slightly
higher birth weights in Indian immigrants in the West compared
to the native Indian babies [22,23]. The existence of other genetic
variants influencing birth weight in the Indian setting is possible,
but rather unlikely considering the considerable genetic diversity
in India [24] contrasted with the uniformity in the low birth weight
phenotype.
The ADCY5 variant has been associated with increased plasma
fasting glucose at a genome-wide level [15] and it appears that,
type 2 diabetes genes in general are reproduced in Indians [25]. In
the current study, rs9883204 variant of ADCY5 was associated with
raised fasting and 2-hour glucose concentrations following an oral
glucose tolerance test performed in early adulthood. Although this
finding would be in general agreement with the fetal-insulin
hypothesis, it is paradoxical compared to a recent study in a large
Danish cohort as another ‘birth weight-lowering’ (rs11708067)
variant was associated with reduced adult insulin resistance [16].
The ADCY5 rs11708067 and rs9883204 are in close linkage
Table 2. Association of glycemic traits with rs9883204 (ADCY5) additive model.
CC CT TT P value{ Effect (95%CI) P value{
n Mean (SD) n Mean (SD) n Mean (SD)
Fasting Glucose (mmol/l) a 1339 5.28 (0.42) 610 5.34 (0.46) 87 5.38 (0.51) 0.13 0.041 (0.004, 0.078) 0.027
2hour Glucose (mmol/l) a 1339 6.34 (1.41) 610 6.19 (1.35) 87 6.40 (1.49) 0.010 0.127 (0.021, 0.233) 0.019
Fasting Insulin (pmol/l) a 1076 36.81 (19.45,61.12) 497 37.50 (21.53,61.12) 75 37.85 (20.48,63.209 0.10 20.008 (20.073, 0.057) 0.81
2 hour Insulin (pmol/l) a 1265 168.07 (100–295.16) 584 153.14 (86.81,255.58) 85 149.32 (82.64,268.07) 0.24 20.058 (20.126, 0.010) 0.010
Insulinogenic Index b,c 992 3.11 (1.39,5.89) 471 2.66 (1.32,5.82) 74 2.44 (1.15,5.16) 0.23 20.106 (20.211, 20.0006) 0.050
AUC glucose b,d 1337 7.12 (6.35,7.91) 610 6.33 (5.74,8.06) 87 7.20 (6.39,8.16) 0.15 0.005 (20.0005, 0.010) 0.08
AUC Insulin b,d 1333 1.22 (0.79,2.01) 608 1.27 (0.72,2.09) 87 1.19 (0.69,2.02) 0.33 20.061 (20.124, 0.002) 0.057
HOMA IR b 1336 1.12 (0.50,1.94) 610 1.02 (0.42,1.86) 87 0.99 (0.37,1.88) 0.63 20.059 (20.016, 0.043) 0.26
HOMA B b 1336 47.20 (24.91,93.09) 610 48.15 (18.79,85.13) 87 44.55 (17.16,86.09) 0.32 20.089 (20.189, 0.012) 0.09
Data represented as amean (SD) and bmedian (Inter-quartile range).
{P values adjusted for gender.
{P values obtained by regression models adjusted for age, gender, consanguinity and BMI.
CInsulinogenic index = (Insulin 30-fasting Insulin) / ( glucose30-fasting glucose).
doi:10.1371/journal.pone.0021331.t002
Table 3. Association of glycemic traits with rs900400 (CCNL1) additive model.
TT TC CC P value{ Effect (95%CI) P value{
n Mean (SD) n Mean (SD) n Mean (SD)
Fasting Glucose (mmol/l) a 1258 5.35 (0.48) 679 5.37 (0.51) 96 5.45 (0.56) 0.18 0.005 (20.002, 0.012) 0.15
2hour Glucose (mmol/l) a 1258 6.31 (1.48) 679 6.40 (1.40) 96 6.24 (1.32) 0.57 0.004 (20.010, 0.108) 0.94
Fasting Insulin (pmol/l) a 1009 37.5 (21.5,62.5) 554 37.5 (19.5,61.1) 87 40.9 (21.5,65.3) 0.82 20.00006 (20.062, 0.063) 0.99
2 hour Insulin (pmol/l) a 1196 146.5 (82.7,261.1) 644 158.4 (90.3,267.7) 91 150.7 (74.3–286.8) 0.35 0.028 (20.039, 0.095) 0.41
Insulinogenic Index b,c 941 2.43 (1.23,5.22) 516 2.62 (1.10,5.63) 81 2.58 (1.03,5.31) 0.92 20.023 (20.127, 0.112) 0.67
AUC glucose b,d 1257 7.19 (6.41,8.12) 678 7.23 (6.38,8.15) 96 7.07 (6.23,7.91) 0.51 0.00005 (20.005, 0.005) 0.99
AUC Insulin bd 1249 1.19 (0.70,1.98) 679 1.23 (0.71,2.12) 96 1.27 (0.78,1.97) 0.48 0.018 (20.043, 0.080) 0.56
HOMA IR b 1254 1.01 (0.39,1.84) 679 0.97 (0.38,1.87) 96 1.29 (0.62,2.08) 0.11 0.073 (20.026, 0.171) 0.15
HOMA B b 1254 45.76 (18.05,86.62) 679 45.99 (18.04,83.44) 96 59.53 (27.22,85.35) 0.17 0.059 (20.039, 0.158) 0.24
Data represented as amean (SD) and bmedian (Inter-quartile range).
{P values adjusted for gender.
{P values obtained by regression models adjusted for age, gender, consanguinity and BMI.
CInsulinogenic index = (Insulin 30-fasting Insulin) / ( glucose30-fasting glucose).
doi:10.1371/journal.pone.0021331.t003
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disequilibrium in the Hapmap CEPH (Utah residents with
ancestry from northern and western Europe) population data (D’
0.93, r2 0.72, Hapmap data rel 27 - http://hapmap.ncbi.nlm.nih.
gov). rs9883204 is not represented in the Hapmap Indian
population (GIH - Gujarathi Indian population), therefore LD
cannot be calculated directly within Hapmap. However, a further
SNP, rs17361324, which is a proxy for rs9883204 in the CEPH
Hapmap data is also a proxy for rs11708067 in the GIH
Hapmap data. This may suggest that, the high LD between these
two SNPs in the CEPH data is also present in the Indian
population and the difference does not appear to be explained by
the genetic architecture and will need confirmation in future
studies. Additionally, the low birth weight and T2DM risk allele of
ADCY5 variant was associated with reduced early insulin response
measured by insulinogenic index, consistent with original report
by Freathy et al., supportive of a possible role in influencing insulin
secretion [1]. It is proposed that ADCY5 risk allele may operate by
different mechanisms by which they influence birth weight and
T2DM risk susceptibility [16], the later probably may be through
an effect on insulin secretion rather than insulin resistance. It is
worth mentioning that for glucose and insulin, the association
detailed in this cohort shows borderline significance and type 2
error cannot be excluded.
The loss of heterozygosity of rs9883204 in our population is
probably related to the high endogamy which is commonly seen
among Indians. It is generally assumed that an association
detected by a well-powered GWAS is in LD with the functional
variant. The strong signals in GWAS are related to the functional
magnitude of the effect and therefore, we assume this holds good
in our population despite a considerable degree of consanguinity.
Although, we have studied, the genetic variants associated with
birth weight in one of the largest and homogenous birth cohorts
from India, our study has limitations. Our study was adequately
powered for CCNL1, but less strong for ADCY5 to explain the
variance observed with these two SNPs. The CV for birth weight
in our study was comparable to originally described and this
further solidifies our power to detect an association. Also the lower
mean birth weight, observed in this population, might potentially
be associated with a reduced overall variance in the dependent
variable, i.e., reduce the effect of the functional variant on birth
weight, which could possibly contribute to the lowered power in
our study. Although it is evident that a multiple comparison
correction would abolish the modest associations with glycemic
traits, we believe that the association is biologically relevant and
that loss of statistical significance by multiple testing does not
necessarily disprove a true association owing to the homogenous
population studied within a small geographical region and the
similar allele frequencies reported among Caucasians [1]. We did
not have the maternal genotype to assess the effect of maternal
genetic variants on birth weight due to non-availability of blood
sample from the mothers. The low number of diabetes cases in this
still young cohort did not allow for observing a possible link
between diabetes incidence and birth weight or genetic links
between them.
In conclusion, the ‘birth weight-lowering’ variants in ADCY5
and near CCNL1 showing strong associations with birth weight in
European cohorts appear to have little or no effect in the Indian
setting. However, the ‘birth weight-lowering’ variant in ADCY5
was associated with modest glucose intolerance in early adulthood
which reinforces the argument for a genetic link between in utero
growth and adult type 2 diabetes.
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